Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Corneal abrasions and corneal foreign bodies: Clinical manifestations and diagnosis

Deborah S Jacobs, MD
Section Editors
Jonathan Trobe, MD
Richard G Bachur, MD
Deputy Editor
James F Wiley, II, MD, MPH


Corneal abrasions are common eye injuries that frequently result from eye trauma, foreign bodies, and improper contact lens use. Patients typically present with severe eye pain and a foreign body sensation. Key aspects of clinical evaluation include exclusion of an open globe and hyphema, measurement of visual acuity, penlight and fluorescein examination, and lid eversion to assess for a conjunctival foreign body. Treatment of small, uncomplicated corneal abrasions consists of topical antibiotic therapy and either topical or oral pain medication. Most abrasions heal fully within 24 hours.

This topic will review the etiology, clinical presentation, diagnosis, and differential diagnosis of corneal abrasions. The management of corneal abrasions, the general approach to a patient with red eye, and the assessment and management of other ocular injuries are discussed separately:

(See "Corneal abrasions and corneal foreign bodies: Management".)

(See "Evaluation of the red eye".)

(See "Open globe injuries: Emergency evaluation and initial management".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 29, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.